FDA Inspection 1065622 — Teva Branded Pharmaceutical Products R&D
The FDA completed an inspection of Teva Branded Pharmaceutical Products R&D on Aug 24, 2018 in Horsham, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 24, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Horsham, PA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)